Herpes Simplex Virus Glycoprotein D: Human Monoclonal Antibody Produced by Bone Marrow Cell Line
- 8 July 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 221 (4606) , 173-175
- https://doi.org/10.1126/science.6304881
Abstract
Normal bone marrow cells from a donor positive for herpes simplex virus were transformed with Epstein-Barr virus. The resulting lymphoblastoid cell line has secreted immunoglobulin G1 of the kappa type continuously for 2 years. This immunoglobulin, detected both on the cell surface and in the cytoplasm, reacts with cells infected with herpes simplex virus. It defines an antigen that comigrates with the 55-kilodalton glycoprotein D of herpes simplex virus type 1 and neutralizes the infectivity of herpes simplex viruses 1 and 2.This publication has 17 references indexed in Scilit:
- Selective induction of autoantibody secretion in human bone marrow by Epstein Barr virus.The Journal of Immunology, 1982
- Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression in Escherichia coliScience, 1982
- Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.The Journal of Immunology, 1982
- Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytesNature, 1980
- Induction of Reaginic HypersensitivityJapanese Journal of Clinical Immunology, 1979
- Production of Antibody to Tetanus Toxoid by Continuous Human Lymphoblastoid Cell LinesScience, 1978
- Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitroNature, 1977
- Herpes Simplex-Raji(A44), a New Cell Line for Serologic Testing by ImmunofluorescenceThe Journal of Immunology, 1976
- SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTESThe Journal of Experimental Medicine, 1973
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973